These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 38653825)

  • 1. Analysis of the action mechanisms and targets of herbal anticonvulsants highlights opportunities for therapeutic engagement with refractory epilepsy.
    Tabassum S; Shorter S; Ovsepian SV
    J Mol Med (Berl); 2024 Jun; 102(6):761-771. PubMed ID: 38653825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Pharmacology and Clinical Efficacy of Antiseizure Medications: From Bromide Salts to Cenobamate and Beyond.
    Löscher W; Klein P
    CNS Drugs; 2021 Sep; 35(9):935-963. PubMed ID: 34145528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMPK role in epilepsy: a promising therapeutic target?
    Qi Y; Zhang YM; Gao YN; Chen WG; Zhou T; Chang L; Zang Y; Li J
    J Neurol; 2024 Feb; 271(2):748-771. PubMed ID: 38010498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric population.
    D'Onofrio G; Roberti R; Riva A; Russo E; Verrotti A; Striano P; Belcastro V
    Neurotherapeutics; 2024 Apr; 21(3):e00344. PubMed ID: 38521667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabis for the Treatment of Epilepsy: an Update.
    Gaston TE; Szaflarski JP
    Curr Neurol Neurosci Rep; 2018 Sep; 18(11):73. PubMed ID: 30194563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicinal plants for epileptic seizures: Phytoconstituents, pharmacology and mechanisms revisited.
    He X; Chen X; Yang Y; Xie Y; Liu Y
    J Ethnopharmacol; 2024 Feb; 320():117386. PubMed ID: 37956914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dietary effects on antiseizure drug metabolism and management of epilepsy.
    Tayutivutikul N; Wanleenuwat P; Panapongvasin T; Klajing R; Iwanowski P
    Seizure; 2022 Nov; 102():14-21. PubMed ID: 36156390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic and clinical foundations of cannabidiol therapy for difficult-to-treat seizures in children and adults with refractory epilepsies.
    Reddy DS
    Exp Neurol; 2023 Jan; 359():114237. PubMed ID: 36206806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research advances in basic mechanisms of seizures and antiepileptic drug action.
    Lasoń W; Chlebicka M; Rejdak K
    Pharmacol Rep; 2013; 65(4):787-801. PubMed ID: 24145073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Continuing Burden of Refractory Epilepsy.
    Janson MT; Bainbridge JL
    Ann Pharmacother; 2021 Mar; 55(3):406-408. PubMed ID: 32795085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs in the development of resistance to antiseizure drugs and their potential as biomarkers in pharmacoresistant epilepsy.
    Bohosova J; Vajcner J; Jabandziev P; Oslejskova H; Slaby O; Aulicka S
    Epilepsia; 2021 Nov; 62(11):2573-2588. PubMed ID: 34486106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet.
    Rogawski MA; Löscher W; Rho JM
    Cold Spring Harb Perspect Med; 2016 May; 6(5):. PubMed ID: 26801895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
    Chi X; Huang C; Li R; Wang W; Wu M; Li J; Zhou D
    J Mol Neurosci; 2017 Apr; 61(4):553-562. PubMed ID: 28229367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.
    Löscher W
    CNS Drugs; 2002; 16(10):669-94. PubMed ID: 12269861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural product-derived therapies for treating drug-resistant epilepsies: From ethnopharmacology to evidence-based medicine.
    Challal S; Skiba A; Langlois M; Esguerra CV; Wolfender JL; Crawford AD; Skalicka-Woźniak K
    J Ethnopharmacol; 2023 Dec; 317():116740. PubMed ID: 37315641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of action of currently used antiseizure drugs.
    Sills GJ; Rogawski MA
    Neuropharmacology; 2020 May; 168():107966. PubMed ID: 32120063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.
    Stefanović S; Janković SM; Novaković M; Milosavljević M; Folić M
    Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):153-159. PubMed ID: 29268032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Characterization in Rodent Seizure and Epilepsy Models.
    Leclercq K; Matagne A; Provins L; Klitgaard H; Kaminski RM
    J Pharmacol Exp Ther; 2020 Jan; 372(1):11-20. PubMed ID: 31619464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticonvulsant Classes and Possible Mechanism of Actions.
    Abd-Allah WH; El-Mohsen Anwar MA; Mohammed ER; El Moghazy SM
    ACS Chem Neurosci; 2023 Dec; 14(23):4076-4092. PubMed ID: 37948544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologically targeting transient receptor potential channels for seizures and epilepsy: Emerging preclinical evidence of druggability.
    Jiang J; Yu Y
    Pharmacol Ther; 2023 Apr; 244():108384. PubMed ID: 36933703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.